Keurig Dr Pepper Inc. (NASDAQ:KDP) Shares Sold by Atria Investments Inc

Atria Investments Inc cut its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDPFree Report) by 9.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 29,721 shares of the company’s stock after selling 2,923 shares during the quarter. Atria Investments Inc’s holdings in Keurig Dr Pepper were worth $1,049,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. First Trust Direct Indexing L.P. boosted its position in shares of Keurig Dr Pepper by 1.7% in the 1st quarter. First Trust Direct Indexing L.P. now owns 21,063 shares of the company’s stock worth $743,000 after buying an additional 346 shares in the last quarter. ASB Consultores LLC boosted its position in shares of Keurig Dr Pepper by 4.7% in the 1st quarter. ASB Consultores LLC now owns 7,817 shares of the company’s stock worth $276,000 after buying an additional 351 shares in the last quarter. Securian Asset Management Inc. boosted its position in shares of Keurig Dr Pepper by 0.5% in the 1st quarter. Securian Asset Management Inc. now owns 71,109 shares of the company’s stock worth $2,509,000 after buying an additional 352 shares in the last quarter. Kentucky Retirement Systems boosted its position in shares of Keurig Dr Pepper by 0.6% in the 1st quarter. Kentucky Retirement Systems now owns 67,187 shares of the company’s stock worth $2,370,000 after buying an additional 387 shares in the last quarter. Finally, Unison Advisors LLC boosted its position in shares of Keurig Dr Pepper by 0.7% in the 1st quarter. Unison Advisors LLC now owns 57,880 shares of the company’s stock worth $2,054,000 after buying an additional 393 shares in the last quarter. 52.29% of the stock is owned by institutional investors and hedge funds.

Keurig Dr Pepper Trading Down 0.4 %

Shares of KDP stock opened at $33.28 on Monday. The firm has a market cap of $46.50 billion, a P/E ratio of 29.19, a PEG ratio of 2.74 and a beta of 0.57. Keurig Dr Pepper Inc. has a 1-year low of $30.47 and a 1-year high of $39.80. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.39 and a quick ratio of 0.24. The firm’s 50-day simple moving average is $32.59 and its 200-day simple moving average is $33.13.

Keurig Dr Pepper (NASDAQ:KDPGet Free Report) last posted its earnings results on Thursday, July 27th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.02. The firm had revenue of $3.79 billion during the quarter, compared to the consensus estimate of $3.69 billion. Keurig Dr Pepper had a net margin of 11.00% and a return on equity of 9.72%. The company’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.39 EPS. As a group, equities analysts forecast that Keurig Dr Pepper Inc. will post 1.78 EPS for the current year.

Insider Buying and Selling

In other Keurig Dr Pepper news, insider Karin Rotem-Wildeman bought 47,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was purchased at an average price of $34.37 per share, with a total value of $1,615,390.00. Following the transaction, the insider now owns 56,514 shares in the company, valued at $1,942,386.18. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.81% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on KDP. StockNews.com began coverage on shares of Keurig Dr Pepper in a research report on Wednesday, August 23rd. They issued a “hold” rating on the stock. Barclays upped their target price on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, July 28th. JPMorgan Chase & Co. reduced their target price on shares of Keurig Dr Pepper from $39.00 to $36.00 and set an “overweight” rating on the stock in a report on Monday, July 17th. Morgan Stanley upgraded shares of Keurig Dr Pepper from an “equal weight” rating to an “overweight” rating and set a $37.00 target price on the stock in a report on Thursday, July 6th. Finally, Wedbush reduced their target price on shares of Keurig Dr Pepper from $40.00 to $37.00 in a report on Tuesday, July 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $37.10.

Get Our Latest Analysis on KDP

About Keurig Dr Pepper

(Free Report)

Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages. The Coffee Systems segment manufactures and distributes various finished goods related to its coffee systems, K-Cup pods, and brewers, as well as specialty coffee.

Featured Articles

Want to see what other hedge funds are holding KDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Keurig Dr Pepper Inc. (NASDAQ:KDPFree Report).

Institutional Ownership by Quarter for Keurig Dr Pepper (NASDAQ:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.